CCM
MLAB icon

CAAS Capital Management’s Mesa Laboratories MLAB Stock Holding History

CAAS Capital Management’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-13,046
Closed -$2.83M – 559
2020
Q2 		$2.83M Buy
+13,046
New +$3.01M 0.09% 177

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

CAAS Capital Management's MLAB Position: Q3 2020 in Review

CAAS Capital Management sold out of Mesa Laboratories (MLAB) in Q3 2020, closing a stake of 13,046 shares — an estimated $2.83M sold.

CAAS Capital Management first reported a position in MLAB in Q2 2020 and held it in 1 quarter. The position peaked at $2.83M in Q2 2020. 153 funds tracked by Wall St. Rank hold MLAB as of Q3 2020.

  • CAAS Capital Management reported no remaining Mesa Laboratories position as of Q3 2020 after selling out during the quarter.
  • CAAS Capital Management sold 13,046 Mesa Laboratories shares in Q3 2020, an estimated $2.83M.
  • CAAS Capital Management first reported a position in Mesa Laboratories in Q2 2020 and held it in 1 quarter.
  • CAAS Capital Management's Mesa Laboratories position peaked at $2.83M in Q2 2020.
  • 153 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2020.

Based on CAAS Capital Management's 13F filing for Q3 2020, filed 9 Nov 2020.